iThera in the news

Invicro and iThera Medical announce a strategic partnership to enhance in vivo imaging capabilities with the MSOT inVision optoacoustic imaging platform

April 30, 2019

About

iThera Medical is the leader in optoacoustic imaging (OAI) with a global customer base in preclinical and clinical research.
OAI has the potential to become a widely used clinical diagnostic technique with an initial indication focus on the assessment of muscle perfusion and oxygen saturation in peripheral arterial disease and neuromuscular diseases.

The company was founded in 2010 as a spin-off of the Helmholtz Center Munich and is headquartered in Munich, Germany.

iThera Medical is the leader in optoacoustic imaging (OAI) with a global customer base in preclinical and clinical research. OAI has the potential to become a widely used clinical diagnostic technique with an initial indication focus on the assessment of muscle perfusion and oxygen saturation in peripheral arterial disease and neuromuscular diseases.

The company was founded in 2010 as a spin-off of the Helmholtz Center Munich and is headquartered in Munich, Germany.

For further information, please contact:
Christian Wiest
Phone: +49 (0) 89 700 7449-21
Email: christian.wiest@ithera-medical.com